34-Meter Hybrid-Electric SES Platform for Next-Generation Maritime Control
VANCOUVER, British Columbia, March 30, 2026 (GLOBE NEWSWIRE) -- Reinventy Solutions Corp. is presenting SES-34 (SHARKΩ —...
Company Closes Fiscal Year 2026 with Record Growth; Chris Nelson, CRO, and Andy Fernandez, New GM of AI and Cyber, Key to HYCU's Recent Success
Boston, Massachusetts, March 30, 2026 (GLOBE NEWSWIRE...
Company Confirms Sufficient Liquidity to Execute FY2026 Growth Plan; Related Share Cancellation to Reduce Outstanding Shares to 3,274,828
Singapore, March 30, 2026 (GLOBE NEWSWIRE) -- YY Group Holdin...
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
Teva's biosimilar, PONLIMSI™, is n...